ResearcherSun Yat-sen UniversityNo recent work listed
Xintao Shuai
Matched on ORCID iD 0000-0003-4271-0310; OpenAlex author ID A5033843685. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: none · 2023: 2 papers
Papers 5
- Sono-promoted drug penetration and extracellular matrix modulation potentiate sonodynamic therapy of pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.actbio.2023.02.038↗
- A nanodrug simultaneously inhibits pancreatic stellate cell activation and regulatory T cell infiltration to promote the immunotherapy of pancreatic cancer. Last author DOI 10.1016/j.actbio.2023.08.007↗
- Recent development of gene therapy for pancreatic cancer using non-viral nanovectors. Co-author DOI 10.1039/d1bm00748c↗
- Correction: Recent development of gene therapy for pancreatic cancer using non-viral nanovectors. Co-author DOI 10.1039/d1bm90082j↗
- Combination of siRNA-directed Kras oncogene silencing and arsenic-induced apoptosis using a nanomedicine strategy for the effective treatment of pancreatic can… Co-author DOI 10.1016/j.nano.2013.08.007↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yong Wang · 3 shared papers, 2014–2023 · strength 0.42
- Paper A nanodrug simultaneously inhibits pancreatic stellate cell activation and regulatory T cell infiltration to promote th… DOI 10.1016/j.actbio.2023.08.007↗
- Paper Sono-promoted drug penetration and extracellular matrix modulation potentiate sonodynamic therapy of pancreatic ductal … DOI 10.1016/j.actbio.2023.02.038↗
- Paper Combination of siRNA-directed Kras oncogene silencing and arsenic-induced apoptosis using a nanomedicine strategy for t… DOI 10.1016/j.nano.2013.08.007↗
- Wei Wu · 2 shared papers, 2021 · strength 0.28
- Rongze Wang · 1 shared paper, 2023 · strength 0.19
- Hong Ping Xiao · 1 shared paper, 2023 · strength 0.18
- Yu Liu · 1 shared paper, 2021 · strength 0.14
- Yu Liu · 1 shared paper, 2021 · strength 0.14
- Zhao Meng Peng · 1 shared paper, 2021 · strength 0.14
- Peng Zhao · 1 shared paper, 2021 · strength 0.14
- Yinting Chen · 1 shared paper, 2014 · strength 0.04
- Qiubo Zhang · 1 shared paper, 2014 · strength 0.04
- Linjuan Zeng · 1 shared paper, 2014 · strength 0.04
- Kaihong Huang · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.